AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19761951 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Interpersonal Psychotherapy plus massage therapy (20 min sessions, once per week for 6 weeks)
Number of subjects: 112
Study 19761951 — intervention group
Group type: COMPARATOR
Intervention: Group Interpersonal Psychotherapy (1h sessions, once per week for 6 weeks)
Number of subjects: 112
Study 16386341 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenderfoot
Number of subjects: 340
Study 16386341 — intervention group
Group type: COMPARATOR
Intervention: Genie Lancet
Number of subjects: 340
Study 12000205 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise with bright light (2500-4000 lux)
Number of subjects: 98
Study 12000205 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise with normal illumination
Number of subjects: 98
Study 12000205 — intervention group
Group type: COMPARATOR
Intervention: Relaxation/stretching sessions in bright light
Number of subjects: 98
Study 10460375 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol (270 mg I/ml)
Number of subjects: 100
Study 10460375 — intervention group
Group type: COMPARATOR
Intervention: Iohexol (300 mg I/ml)
Number of subjects: 100
Study 7599293 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone 0.2 IU
Number of subjects: 36
Study 7599293 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone 0.7 IU
Number of subjects: 36
Study 7599293 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 36
Study 7599293 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone 0.02 IU
Number of subjects: 36
Study 7599293 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone 2 IU
Number of subjects: 36
Study 7599293 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle) in group 3
Number of subjects: 36
Study 2296215 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-containment educational program involving senior physicians, lectures, comparative feedback, chart reviews, and small group discussions.
Number of subjects: 0
Study 2296215 — intervention group
Group type: COMPARATOR
Intervention: Control group interns (not specified how they were educated or trained).
Number of subjects: 0
Study 675728 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonographic examination (grey scale)
Number of subjects: 51
Study 675728 — intervention group
Group type: COMPARATOR
Intervention: Lymphographic examination
Number of subjects: 51
Study 29526833 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg loading dose (LD) 24 hours after the last maintenance dose (MD) of ticagrelor (C-600 mg-24h)
Number of subjects: 80
Study 29526833 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg loading dose (LD) 12 hours after the last maintenance dose (MD) of ticagrelor (C-600 mg-12h)
Number of subjects: 80
Study 29526833 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 75 mg/d maintenance dose (C-75 mg-24h)
Number of subjects: 80
Study 29526833 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily maintenance dose (T-90 mg twice daily)
Number of subjects: 80
Study 27676149 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster set configurations
Number of subjects: 10
Study 25330838 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial bright light treatment via ear canals (1 lumen/0.72 mW/cm(2))
Number of subjects: 89
Study 25330838 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial bright light treatment via ear canals (4 lumens/2.881 mW/cm(2))
Number of subjects: 89
Study 25330838 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial bright light treatment via ear canals (9 lumens/6.482 mW/cm(2))
Number of subjects: 89
Study 23185073 — intervention group
Group type: EXPERIMENTAL
Intervention: V-Loc 90 barbed sutures
Number of subjects: 30
Study 23185073 — intervention group
Group type: COMPARATOR
Intervention: Conventional 3-layer closure with nonbarbed sutures
Number of subjects: 30
Study 21108056 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 ml of 12.5% glucose solution the night before surgery and 200 ml two hours before surgery (Group A)
Number of subjects: 60
Study 21108056 — intervention group
Group type: COMPARATOR
Intervention: Distilled water instead of glucose (Group B)
Number of subjects: 60
Study 21108056 — intervention group
Group type: COMPARATOR
Intervention: Fasting for 8‐12 hours before operation (Group C)
Number of subjects: 60
Study 19143586 — intervention group
Group type: EXPERIMENTAL
Intervention: EPP's lay-led skills training
Number of subjects: 0
Study 15745775 — intervention group
Group type: EXPERIMENTAL
Intervention: gatifloxacin 0.3%
Number of subjects: 52
Study 12357299 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg EPI/30 ml saline 19 times over 1 year (arm A)
Number of subjects: 125
Study 12357299 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg EPI/30 ml 12 times over 5 months (arm B)
Number of subjects: 125
Study 9796041 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP or DTP vaccine
Number of subjects: 0
Study 9796041 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertactin value < 7 EU ml‐1
Number of subjects: 0
Study 9796041 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertactin value >= 7 EU ml‐1 and PT value >= 66 EU ml‐1
Number of subjects: 0
Study 9796041 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertactin value >= 7 EU ml‐1 and PT value < 66 EU ml‐1
Number of subjects: 0
Study 9796041 — intervention group
Group type: EXPERIMENTAL
Intervention: High versus low pertactin values
Number of subjects: 0
Study 9796041 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of antibody to pertactin, PT and fimbriae‐2
Number of subjects: 0
Study 9796041 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent vaccines containing pertactin and fimbriae
Number of subjects: 0
Study 7636684 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-based oral rehydration solution (50 g/L)
Number of subjects: 100
Study 7636684 — intervention group
Group type: COMPARATOR
Intervention: Glucose-based WHO/UNICEF solution
Number of subjects: 100
Study 2613606 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin plus amphotericin-B
Number of subjects: 34
Study 2613606 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulphamethoxazole
Number of subjects: 34
Study 2613606 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime (monotherapy)
Number of subjects: 34
Study 2613606 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime plus tobramycin (combination therapy)
Number of subjects: 34
Study 2613606 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime plus piperacillin
Number of subjects: 34
Study 2613606 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin plus amikacin
Number of subjects: 34
Study 19807 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 1.2 mg
Number of subjects: 8
Study 19807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31835096 — intervention group
Group type: EXPERIMENTAL
Intervention: Assert intervention
Number of subjects: 150
Study 31835096 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 31669625 — intervention group
Group type: EXPERIMENTAL
Intervention: Anagliptin (200 mg/day)
Number of subjects: 24
Study 31669625 — intervention group
Group type: COMPARATOR
Intervention: Metformin (1000 mg/day)
Number of subjects: 24
Study 27342581 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodiafiltration (HDF)
Number of subjects: 396
Study 27342581 — intervention group
Group type: COMPARATOR
Intervention: Hemodialysis (HD)
Number of subjects: 396
Study 27342581 — intervention group
Group type: EXPERIMENTAL
Intervention: High serum sclerostin (sScl)
Number of subjects: 396
Study 25627123 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-thickness autograft combined with harvested skin cell suspension
Number of subjects: 88
Study 25627123 — intervention group
Group type: COMPARATOR
Intervention: Split-thickness autograft alone (Control)
Number of subjects: 88
Study 24318319 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma nail
Number of subjects: 80
Study 24318319 — intervention group
Group type: COMPARATOR
Intervention: AMBI sliding hip screw
Number of subjects: 80
Study 22463757 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-enhanced learning (TEL) group
Number of subjects: 42
Study 22463757 — intervention group
Group type: COMPARATOR
Intervention: Traditional face-to-face group
Number of subjects: 42
Study 19119028 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 213
Study 19119028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 19119028 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 213
Study 19119028 — intervention group
Group type: EXPERIMENTAL
Intervention: No Statins
Number of subjects: 213
Study 17440685 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-3 drops of 5% povidone iodine (drops group)
Number of subjects: 28
Study 17440685 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml flush of 5% povidone iodine (flush group)
Number of subjects: 28
Study 17440685 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 28
Study 15383800 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvimopan 6 mg
Number of subjects: 510
Study 15383800 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvimopan 12 mg
Number of subjects: 510
Study 15383800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 510
Study 11297484 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 549
Study 9671379 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution
Number of subjects: 35
Study 9671379 — intervention group
Group type: COMPARATOR
Intervention: Hypertonic saline
Number of subjects: 35
Study 8005548 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) plus ethinyl estradiol (EE)
Number of subjects: 17
Study 8005548 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate (CC)
Number of subjects: 17
Study 29775015 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Dilatation Tracheostomy (PDT)
Number of subjects: 1200
Study 29775015 — intervention group
Group type: COMPARATOR
Intervention: Traditional Tracheostomy (TT)
Number of subjects: 1200
Study 29775015 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT
Number of subjects: 1200
Study 27814738 — intervention group
Group type: EXPERIMENTAL
Intervention: Organisational support only (Group ORG)
Number of subjects: 153
Study 27814738 — intervention group
Group type: EXPERIMENTAL
Intervention: Organisational support plus LUMOback activity tracker (Group ORG + Tracker)
Number of subjects: 153
Study 27814738 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group ORG)
Number of subjects: 153
Study 25437483 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated corneal cross-linking
Number of subjects: 153
Study 25437483 — intervention group
Group type: COMPARATOR
Intervention: Conventional corneal cross-linking
Number of subjects: 153
Study 23359581 — intervention group
Group type: EXPERIMENTAL
Intervention: Take Care technique (early surfactant treatment via thin catheter)
Number of subjects: 200
Study 23359581 — intervention group
Group type: COMPARATOR
Intervention: InSurE technique (intubation, surfactant instillation, positive pressure ventilation)
Number of subjects: 200
Study 23359581 — intervention group
Group type: EXPERIMENTAL
Intervention: Take Care technique
Number of subjects: 200
Study 20592122 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired-pulse transcranial magnetic stimulation (ppTMS)
Number of subjects: 0
Study 20592122 — intervention group
Group type: COMPARATOR
Intervention: Single-pulse transcranial magnetic stimulation (spTMS)
Number of subjects: 0
Study 19395578 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg infliximab
Number of subjects: 130
Study 19395578 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg infliximab
Number of subjects: 130
Study 19395578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 19395578 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg infliximab and 5 mg/kg infliximab
Number of subjects: 130
Study 16984575 — intervention group
Group type: EXPERIMENTAL
Intervention: Graftjacket tissue matrix plus mineral oil-soaked fluff compression dressing
Number of subjects: 28
Study 16984575 — intervention group
Group type: COMPARATOR
Intervention: Wound gel with gauze dressings
Number of subjects: 28
Study 16984575 — intervention group
Group type: EXPERIMENTAL
Intervention: Graftjacket tissue matrix
Number of subjects: 28
Study 12764908 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetramethylpyrazine (TMP) 3 mg/kg intravenously after anesthesia induction and 1 mg/kg in oxygenator during CPB
Number of subjects: 30
Study 12764908 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TMP treatment)
Number of subjects: 30
Study 11015087 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass graft (OP-CAB) procedures
Number of subjects: 100
Study 11015087 — intervention group
Group type: COMPARATOR
Intervention: Conventional coronary artery bypass grafting procedures
Number of subjects: 100
Study 9336104 — intervention group
Group type: EXPERIMENTAL
Intervention: Keyswitch make force of 1.02 N
Number of subjects: 10
Study 9336104 — intervention group
Group type: COMPARATOR
Intervention: Keyswitch make force of 0.47 N
Number of subjects: 10
Study 9336104 — intervention group
Group type: COMPARATOR
Intervention: Keyswitch make force of 0.34 N
Number of subjects: 10
Study 8103650 — intervention group
Group type: EXPERIMENTAL
Intervention: Org 9487 without neostigmine
Number of subjects: 45
Study 8103650 — intervention group
Group type: EXPERIMENTAL
Intervention: Org 9487 with neostigmine
Number of subjects: 45
Study 8103650 — intervention group
Group type: COMPARATOR
Intervention: Succinylcholine
Number of subjects: 45
Study 3079625 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 346
Study 3079625 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 346
Study 31388990 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholera vaccination
Number of subjects: 73000
Study 30096265 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon phototherapy of the stellate ganglion (XPSG)
Number of subjects: 43
Study 30096265 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (non-XPSG)
Number of subjects: 43
Study 25800863 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Stress Management Program (ISMP), 8 sessions of 2 hours each over 4 weeks
Number of subjects: 99
Study 25800863 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 99
Study 24746263 — intervention group
Group type: COMPARATOR
Intervention: Written advice (control)
Number of subjects: 131
Study 24746263 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief GP advice (written advice plus GP advice on physical activity)
Number of subjects: 131
Study 24746263 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief GP advice plus a pedometer to self-monitor physical activity
Number of subjects: 131
Study 22574757 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care intervention programme
Number of subjects: 176
Study 22574757 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 176
Study 20931823 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 50
Study 20931823 — intervention group
Group type: COMPARATOR
Intervention: Oral anticoagulants
Number of subjects: 50
Study 18291584 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR) for 25 minutes
Number of subjects: 55
Study 18291584 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 55
Study 16204713 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid scanning protocol (4 min total: 3 min emission, 1 min transmission)
Number of subjects: 105
Study 16204713 — intervention group
Group type: COMPARATOR
Intervention: Conventional scanning protocol (20 min total: 10 min emission, 10 min transmission)
Number of subjects: 105
Study 12127464 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard outpatient alcoholism treatment (ST)
Number of subjects: 0
Study 12127464 — intervention group
Group type: COMPARATOR
Intervention: Minimal treatment (MT)
Number of subjects: 0
Study 10403865 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulation (spending at least 20 min of every hour out of bed)
Number of subjects: 229
Study 10403865 — intervention group
Group type: COMPARATOR
Intervention: Staying in bed
Number of subjects: 229
Study 7586434 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm bypass (31.8 +/‐ 0.4 degrees C)
Number of subjects: 20
Study 7586434 — intervention group
Group type: COMPARATOR
Intervention: Cold bypass (26.3 +/‐ 0.5 degrees C)
Number of subjects: 20
Study 1693111 — intervention group
Group type: EXPERIMENTAL
Intervention: Otomize (neomycin/dexamethasone spray)
Number of subjects: 60
Study 1693111 — intervention group
Group type: COMPARATOR
Intervention: Sofradex (framycetin/gramicidin/dexamethasone drops)
Number of subjects: 60
Study 6988936 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 88
Study 6988936 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 31269025 — intervention group
Group type: EXPERIMENTAL
Intervention: SPG stimulation
Number of subjects: 98
Study 31269025 — intervention group
Group type: COMPARATOR
Intervention: NINDS rt-PA trial placebo patients
Number of subjects: 98
Study 28630183 — intervention group
Group type: EXPERIMENTAL
Intervention: SDF variant 1
Number of subjects: 0
Study 28630183 — intervention group
Group type: EXPERIMENTAL
Intervention: SDF variant 2
Number of subjects: 0
Study 28630183 — intervention group
Group type: COMPARATOR
Intervention: Conventional formulation
Number of subjects: 0
Study 26423050 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL mepivacaine 1.5%
Number of subjects: 45
Study 26423050 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mL mepivacaine 1%
Number of subjects: 45
Study 26423050 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mL mepivacaine 1.5%
Number of subjects: 45
Study 23551510 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper™ rotary system
Number of subjects: 20
Study 23551510 — intervention group
Group type: COMPARATOR
Intervention: ProTaper Universal™ rotary system
Number of subjects: 20
Study 20934685 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural treatment (n=17)
Number of subjects: 34
Study 20934685 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list condition (n=17)
Number of subjects: 34
Study 19038389 — intervention group
Group type: EXPERIMENTAL
Intervention: Staccato reperfusion (SR)
Number of subjects: 37
Study 19038389 — intervention group
Group type: COMPARATOR
Intervention: Abrupt reperfusion (AR)
Number of subjects: 37
Study 17005527 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 12
Study 17005527 — intervention group
Group type: COMPARATOR
Intervention: Cinacalcet withdrawal
Number of subjects: 12
Study 15764014 — intervention group
Group type: EXPERIMENTAL
Intervention: Stressor before retrieval
Number of subjects: 60
Study 15764014 — intervention group
Group type: EXPERIMENTAL
Intervention: Stressor before learning
Number of subjects: 60
Study 15764014 — intervention group
Group type: COMPARATOR
Intervention: No stress
Number of subjects: 60
Study 11369156 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg intravenous infusion over one hour)
Number of subjects: 12
Study 11369156 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution intravenous infusion over one hour)
Number of subjects: 12
Study 8988992 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-based anesthesia (5 mg.kg‐1.h‐1 prior to sternotomy, 3 mg.kg‐1.h‐1 thereafter)
Number of subjects: 124
Study 8988992 — intervention group
Group type: COMPARATOR
Intervention: Enflurane-based anesthesia (0.2%-1.0%)
Number of subjects: 124
Study 8988992 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 124
Study 8213569 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional coronary atherectomy (DCA)
Number of subjects: 100
Study 2956957 — intervention group
Group type: EXPERIMENTAL
Intervention: cilostazol (CS)
Number of subjects: 9
Study 2956957 — intervention group
Group type: EXPERIMENTAL
Intervention: ticlopidine (TP)
Number of subjects: 9
Study 2956957 — intervention group
Group type: EXPERIMENTAL
Intervention: acetylsalicylic acid (ASA)
Number of subjects: 9
Study 30950283 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening Training (EG)
Number of subjects: 52
Study 30950283 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning Training (MG)
Number of subjects: 52
Study 30950283 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 52
Study 28731562 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based behavioural weight loss intervention
Number of subjects: 90
Study 28731562 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 90
Study 25365133 — intervention group
Group type: EXPERIMENTAL
Intervention: HIP protocol
Number of subjects: 199
Study 25365133 — intervention group
Group type: COMPARATOR
Intervention: KNEE protocol
Number of subjects: 199
Study 22766268 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human bone morphogenetic protein‐7 (rhBMP‐7) with deproteinised bone substitute (0.5 g)
Number of subjects: 9
Study 22766268 — intervention group
Group type: COMPARATOR
Intervention: deproteinised bone alone (2.0 g)
Number of subjects: 9
Study 20147570 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 µg dDAVP combined with 10 µg hCRH
Number of subjects: 12
Study 20147570 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 µg dDAVP combined with 30 µg hCRH
Number of subjects: 12
Study 20147570 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 µg dDAVP alone
Number of subjects: 12
Study 20147570 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 µg hCRH administered two hours after 10 µg dDAVP
Number of subjects: 12
Study 20147570 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 µg dDAVP followed by 100 µg hCRH
Number of subjects: 12
Study 19190453 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic cortical venous drainage (aCVD)
Number of subjects: 28